Tag: Pharma acquisition news

AstraZeneca to acquire Amolyt Pharma in $1.05bn deal to expand rare disease portfolio

businessnewstoday- March 15, 2024

AstraZeneca has announced a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on novel treatments for rare endocrine diseases, in a deal ... Read More

Gilead Sciences to acquire CymaBay Therapeutics to enhance liver disease portfolio

businessnewstoday- February 14, 2024

In a significant move within the biopharmaceutical industry, Gilead Sciences, Inc. (Nasdaq: GILD) has confirmed its acquisition of CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for a ... Read More

Jazz Pharmaceuticals to acquire Redx Pharma’s KRAS inhibitor program to expand oncology pipeline

businessnewstoday- February 7, 2024

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and Redx Pharma plc (AIM: REDX) have entered into a definitive agreement, marking a significant milestone in the development of ... Read More

Novartis announces takeover bid for MorphoSys AG to boost oncology pipeline

businessnewstoday- February 6, 2024

In a significant move within the pharmaceutical industry, Novartis has entered into an agreement to launch a voluntary public takeover offer to acquire MorphoSys AG, ... Read More

AVROBIO announces merger with Tectonic Therapeutic in significant all-stock deal

businessnewstoday- January 30, 2024

AVROBIO, Inc. (Nasdaq: AVRO) and Tectonic Therapeutic, Inc., a biotechnology firm specializing in GPCR (G-protein coupled receptor)-targeted therapeutic proteins, have announced a definitive merger agreement. ... Read More

Sandoz to acquire biosimilar CIMERLI from Coherus BioSciences to expand ophthalmology portfolio

businessnewstoday- January 24, 2024

In a significant development within the pharmaceutical and healthcare industry, Sandoz, a global leader in generic and biosimilar medicines, announced its strategic acquisition of the ... Read More

Merck to acquire Harpoon Therapeutics for $680m to strengthen oncology pipeline

businessnewstoday- January 9, 2024

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Harpoon Therapeutics, Inc. (Nasdaq: HARP) have entered a definitive agreement where Merck ... Read More

GSK to acquire Aiolos Bio to expand respiratory treatment portfolio

businessnewstoday- January 9, 2024

GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) have announced a significant agreement, where GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focusing on ... Read More

AstraZeneca to acquire Gracell Biotechnologies for $1.2bn to expand cell therapy capabilities

businessnewstoday- January 2, 2024

AstraZeneca has announced a definitive agreement to acquire Gracell Biotechnologies Inc. (Gracell, NASDAQ: GRCL) for an upfront cash payment of $1.0 billion, representing a 62% ... Read More

Eli Lilly and Company completes $1.4bn acquisition of POINT Biopharma

businessnewstoday- December 31, 2023

Eli Lilly and Company (NYSE: LLY) has announced the successful completion of its $1.4 billion acquisition of POINT Biopharma Global Inc. (NASDAQ: PNT), a notable ... Read More